In search of an optimum dose escalation for narrowband UVB phototherapy: Is it time to quit 20% increments?

Journal of the American Academy of Dermatology

Volumn 55, Issue 2, 2006, Pages 269-271

  Boztepe, Gonca ^a   Akinci, Hande ^a   Şahin, Sedef ^a   Karaduman, Aysen ^a   Evans, Sibel Ersoy ^a   Erkin, Gül ^a   Atakan, Nilgün ^a   Akan, Tülin ^a   Kölemen, Fikret ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DOSIMETRY; ERYTHEMA; HUMAN; MAJOR CLINICAL STUDY; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

ERYTHEMA; FEMALE; HUMANS; MALE; PHOTOTHERAPY; PSORIASIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; ULTRAVIOLET RAYS;

EID: 33745816379     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.04.019     Document Type: Article

References (10)

1. Hofer A., Fink-Puches R., Kerl H., and Wolf P. Comparison of phototherapy with near vs. far erythemogenic doses of narrow-band UVB in patients with psoriasis. Br J Dermatol 138 (1998) 96-100
2. Cameron H., Dawe R.S., Yule S., Main I., Wainwright N.J., Ibbotson S.H., et al. A randomized, observer-blinded trial of twice vs. three times weekly narrowband UVB phototherapy for chronic plaque psoriasis. Br J Dermatol 147 (2002) 973-978
3. Dawe R.S., Wainwright N.J., Cameron H., and Ferguson J. Narrow-band (TL-01) UVB phototherapy for chronic plaque psoriasis: three times or five times weekly treatment?. Br J Dermatol 138 (1998) 833-839
4. Wainwright N.J., Dawe R.S., and Ferguson J. Narrowband UVB (TL-01) phototherapy for psoriasis: which incremental regimen?. Br J Dermatol 139 (1998) 410-414
5. Fitzpatrick T.B. Soleil et peau. J Med Esthet 2 (1975) 33
6. Gordon P.M., Saunders P.J., Diffey B.L., and Farr P.M. Phototesting prior to narrowband (TL-01) UVB phototherapy. Br J Dermatol 139 (1998) 811-814
7. Green C., Lakshmipathi T., Johnson B.E., and Ferguson J. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs. etretinate (re-TL-01) vs. etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients. Br J Dermatol 127 (1992) 5-9
8. Ibbotson S.H., Bilsland D., Cox N.H., Dawe R.S., Diffey B., Edwards C., et al. An update and guidance on narrowband UVB phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol 151 (2004) 283-297
9. Lim J.L., and Stern R.S. High levels of UVB exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. J Invest Dermatol 124 (2005) 505-513
10. Man I., Crombie I.K., Dawe R.S., Ibbotson S.H., and Ferguson J. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data. Br J Dermatol 152 (2005) 755-757